Medical/Pharmaceuticals
Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals
* Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient's clinical characteristics and will be studied for its impact on inpatient pharmacist efficacy and efficiency. * The Synapse Medicine medication reconciliation tool will be deployed throu...
2022-10-07 07:05
2745
TauRx Announces Results from Phase 3 Alzheimer's Disease Study, LUCIDITY, Assuring Path for Regulatory Submissions
* For people with early Alzheimer's (MCI), HMTM treatment resulted in sustained improvement in cognition over pre-treatment baseline, and normalisation of brain atrophy to a rate similar to healthy individuals * For people with mild to moderate Alzheimer's, HMTM stabilised cognition and funct...
2022-10-06 18:00
2600
AWARD-WINNING SKINPEN® PRECISION ANNOUNCES NEW AND EXPANDED APPROVED INDICATIONS
Solidifies Status as the Leading, Most Advanced Skin Remodeling Treatment System DALLAS, Oct. 6, 2022 /PRNewswire/ -- Crown Aesthetics ("Crown"), a division of Crown Laboratories and inventors of the award-winningSkinPen Precision, announced today that its revolutionary device has received three ...
2022-10-06 14:30
2192
Cytiva strengthens cell line development with CEVEC acquisition
* Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies * 46 scientific experts based in Cologne, Germany, join the Cytiva team in the genomic medicine space * Cytiva customers will have immediate access to technologies that solve som...
2022-10-06 14:00
2255
Servier unveils its 2030 ambition and reveals a new visual identity
* A new ambition by 2030 to accelerate its transformation dynamic * A visual identity, a marker of the successful transformation of the Group, its ambitions and its renewal PARIS, Oct. 6, 2022 /PRNewswire/ -- Servier today unveils its 2030 ambition as well as a new visual identity that reflec...
2022-10-06 13:30
2601
ASTRAZENECA, First Organization in Egypt receiving Best place to work for Millennials Award
CAIRO, Oct. 5, 2022 /PRNewswire/ -- AstraZeneca Egypt, was recently certified as a Best Place to Work for Millennials marking it the first organization in Egypt to receive such award. The certification is based on an HR analysis of the company policies focusing on Millennials and an anonymous emp...
2022-10-05 22:59
1788
Ascletis Announces Dosing of the First Patient in Phase II Clinical Trial of THRβ Agonist ASC41 for 52-Week Treatment of Liver Biopsy-Proven NASH
-- ASC41 is ranking first in China and third in the world in terms of clinical progress as a thyroid hormone receptor β (THRβ) agonist drug candidate for non-alcoholic steatohepatitis (NASH). ASC41 Phase II clinical trial is currently the most advanced 52-week Phase II clinical trial which is in...
2022-10-05 08:10
3953
Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting Antibody TST004 for the Treatment of IgA Nephropathy
SUZHOU, China, Oct. 5, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that TST004, its best...
2022-10-05 08:00
3285
HAVAS HEALTH & YOU APPOINTS PAUL PFLEIDERER AS PRESIDENT OF HAVAS LIFE NEW YORK
NEW YORK, Oct. 4, 2022 /PRNewswire/ -- As the rapid evolution of the health and wellness sector continues to necessitate innovative thinking and activation across the industry, Havas Health & You today announced that it has appointed seasoned strategic leaderPaul Pfleiderer as President of Havas ...
2022-10-04 21:00
1613
RevitaLash® Cosmetics Champions Breast Cancer Awareness, Research, and Support Worldwide with 2022 Pink Program Announcement
The Mission-Driven Lash & Brow Leader Expands Its Year-Round Breast Cancer Awareness Efforts Globally VENTURA, Calif., Oct. 4, 2022 /PRNewswire/ -- RevitaLash® Cosmetics is proud to announce the company's annual 2022 Pink Program campaign. In honor of Breast Cancer Awareness month, RevitaLash® C...
2022-10-04 20:43
5353
GHA's HealthStars EXCELerator: Driving Business and Healthcare Outcomes through Innovation
WEST PALM BEACH, Fla., Oct. 4, 2022 /PRNewswire/ -- Global Healthcare
Accreditation (GHA) announces the launch of HealthStars EXCELerator, a program
designed to accelerate innovation and maximize a businesses' opportunity for
success in the global healthcare space.
2022-10-04 18:00
3011
Pacertool Establishes World-Class Scientific Advisory Board
The Scientific Advisory Board Will Develop the Company Clinical Trial Strategy, Ensure Alignment with Current Trends in Cardiac Pacing for Heart Failure Patients and Provide Input to the Pacertool Innovation Pipeline. OSLO, Norway, Oct. 4, 2022 /PRNewswire/ -- Pacertool AS, a Norwegian emerging ...
2022-10-04 16:29
2013
Kira Pharmaceuticals Receives FDA Clearance of IND Application for Phase 2 Evaluation of KP104 in Systemic Lupus Erythematosus Associated Thrombotic Microangiopathy (SLE-TMA)
Phase 1 supporting data indicated an encouraging profile and confirmed the dual mechanism of action achieved through targeting both the alternative and terminal complement pathways CAMBRIDGE, Mass., Oct. 3, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering tran...
2022-10-03 19:00
2782
Award Presentation of the "2022 Most Innovative Enterprise Award"
Beyond Creative, Be Innovative HONG KONG, Oct. 3, 2022 /PRNewswire/ -- BUSINESS INNOVATOR successfully held the "2022 Most Innovative Enterprise Award" presentation ceremony on 30th September 2022 at the Island Shangri-La Hotel. The ceremony acknowledges businesses demonstrating remarkable contr...
2022-10-03 17:51
7452
DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY
Debiopharm awards the winning scientists for the JCA (Japanese Cancer
Association) Award for innovative, disruptive, and translational oncology
research
LAUSANNE, Switzerland, Oct. 3, 2022 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
2022-10-03 15:00
2415
Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2023
GOTHENBURG, Sweden, Oct.1, 2022 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee for the company's Annual General Meeting 2023 has been appointed. ...
2022-10-01 00:53
3166
Infinitus Products Received the Hong Kong Q-Mark Certificate
GUANGZHOU, China, Sept. 30, 2022 /PRNewswire/ -- The Q-Mark 43rd Anniversary
cum Presentation Ceremony has been successfully held at the Hong Kong
Convention and Exhibition Centre on2 September 2022. Nine Infinitus Products
Have Received the Hong Kong Q-Mark Product Certification.
2022-09-30 19:23
3309
YS BIOPHARMA TO MERGE WITH NASDAQ-LISTED SUMMIT HEALTHCARE ACQUISITION CORP.
* Transaction values YS Biopharma at pre-money equity value of $834 million * Certain investors ("Forward Purchase Investors") are expected to invest $30 million in a private placement concurrently with the closing of the business combination transaction pursuant to certain forward purchase ag...
2022-09-30 04:01
3280
First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent
MELBOURNE, Australia, Sept. 30, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose inNew Zealand of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known ...
2022-09-30 02:30
3472
Doxy.me extends telemedicine's reach to 88% of the world's population
Doxy.me adds over 100 languages, live interpreters, and global currencies to overcome barriers to telemedicine around the world. CHARLESTON, S.C., Sept. 30, 2022 /PRNewswire/ -- Doxy.me, the web-based telemedicine platform on a mission to make telemedicine available to all, is expanding its capa...
2022-09-29 22:03
2565
Week's Top Stories
Most Reposted
DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 276 media titles]
2026-10-06 05:28Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 271 media titles]
2026-10-01 10:00
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 269 media titles]
2026-09-30 10:50
Sunway University to Host Asia's First Global Tipping Points Conference 2026
[Picked up by 263 media titles]
2026-09-30 12:11
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
23821
